Similar to AD and PD, a reduction in DAPK1 activity prevents the loss of dendritic spines and the synapse dysfunction by normalizing the phosphorylation of extrasynaptic N-methyl-D-aspartate (NMDA) receptors in HD [23]. The gene discussed is DAPK1; the disease is Alzheimer disease.